---
$id: https://graph.org.ai/products/commodity/51131711
$type: Product
source: UNSPSC
code: "51131711"
title: "Tenecteplase"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tenecteplase

**UNSPSC Code**: 51131711
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thrombolytic agent with the molecular formula C2558H3872N738O781S40, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WGD229O42W, more generally known as tenecteplase. European Medicines Agency schedules tenecteplase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04718MIG. The term TENECTEPLASE is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 13 no. 1, 1999, list 41. Most nations schedule tenecteplase under HS 35079090 and SITC 51691. As of Q4 2014, TENECTEPLASE remains the US FDA Preferred Term for this commodity. Tenecteplase bears US NLM identifiers UMLS ID C0872913 and NCI Concept Code C29489. SMILES: NONE.

